Topical nonsteroidal anti-inflammatory drugs for osteoarthritis (Q37810415)

23 August 2017

0 references

Topical nonsteroidal anti-inflammatory drugs for osteoarthritis (English)

1 reference

23 August 2017

0 references

0 references

Robert A Axford-Gatley

series ordinal

2

0 references

author name string

H Richard Barthel

series ordinal

1

1 reference

PubMed ID

21084786

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

23 August 2017

Postgraduate Medicine

1 reference

23 August 2017

122

1 reference

23 August 2017

6

1 reference

23 August 2017

98-106

1 reference

Osteoarthritis: epidemiology

23 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Nonsteroidal anti-inflammatory drugs: effects on kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

TOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomised controlled trial with patient preference study. [ISRCTN79353052].

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2227

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.11.2227

1 reference

23 August 2017

1 reference

PubMed ID

21084786